Petmedexpress - Meinungen & Aussichten - 500 Beiträge pro Seite

[kars10]

Gibt es Meinungen zu Petmedexpress?

Petmed bietet Nahrungsmittel, Pflegeprodukte und Mediakamente für Haustiere über das Internet an.

Wie viel Potential steckt noch in dieser Aktie?

[Koopie242]

es gab eine empfehlung im August im Aktionär: damals lag die prognose bei 14€.


Erwartetes gewinnwachstum 2006 um 26%

nächstes geschäftsjahr schätzungen gewinn je aktie bei 57cent, diese jahr 45cent

[Koopie242]

Petmed Express mit HAMMER ZAHLEN


AP
PetMed Express 3Q Profit Soars on Revenue
Monday January 23, 8:30 am ET
PetMed Express Third-Quarter Earnings Surges 37 Percent, Boosted by Strong Revenue Growth

POMPANO BEACH, Fla. (AP) -- Pet pharmacy PetMed Express Inc. said Monday its third-quarter profit expanded 37 percent, as the company attracted more customers and sales increased.

Net income rose to $2.7 million, or 11 cents per share, compared with $2 million, or 8 cents per share, in the year-ago quarter. Net sales increased 25 percent to $25.9 million from $20.8 million.

Analysts surveyed by Thomson Financial expected the company to earn a more modest 9 cents per share on revenue of $24.9 million.

The company said it acquired roughly 105,000 new customers during quarter compared with 85,000 new customers in the prior-year period. PetMed also noted that its retail new order sales jumped by 26 percent to $7.3 million versus $5.8 million for the year-earlier quarter.

[Koopie242]

Jetzt gehts richtug ab. An der Nasdaq schon über 16-Dollar.
Allzeithoch

[kars10]

Hier nochmal von die ganze Meldung.

Quelle:
http://www.1800petmeds.com/pressroom.asp?id=42&adate=01.23.2…


PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES RECORD THIRD QUARTER FINANCIAL RESULTS - SALES INCREASE 25%, NET INCOME INCREASES 37%

Pompano Beach, Florida, January 23, 2006 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2005. Net sales for the quarter ended December 31, 2005 were $25.9 million, compared to $20.8 million for the quarter ended December 31, 2004, an increase of 25%. Net income was $2.7 million, or $0.11 diluted per share, for the quarter ended December 31, 2005, compared to net income of $2.0 million, or $0.08 diluted per share, for the quarter ended December 31, 2004, an increase to net income of 37%. Net sales for the nine months ended December 31, 2005 were $108.2 million, compared to $84.8 million for the nine months ended December 31, 2004, an increase of 28%. Net income for the nine months ended December 31, 2005 was $8.9 million, or $0.37 diluted per share, compared to net income of $5.6 million, or $0.23 diluted per share, for the nine months ended December 31, 2004, an increase to net income of 60%.

The Company acquired approximately 105,000 new customers during the third fiscal quarter compared to 85,000 new customers for the same quarter in the prior year. Approximately 57% of all orders were placed on the Company`s website during the third fiscal quarter.

Menderes Akdag, CEO and President, commented: "We are pleased to report that our retail new order sales increased by 26% to $7.3 million for the third fiscal quarter compared to $5.8 million for the same quarter in the prior year. The advertising cost of acquiring a new customer for the third fiscal quarter improved to approximately $30 compared to $31 for the same quarter in the prior year. In addition, our retail reorder sales increased by 25%, from $14.5 million to $18.1 million for the quarters ended December 31, 2004 and 2005, respectively. We are also pleased to report that net cash provided by operating activities increased by $10.0 million, from $3.5 million for the nine months ended December 31, 2004 to $13.5 million for the nine months ended December 31, 2005."

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter`s financial results. To access the call which is open to the public, call [phone] (toll free) or [phone]. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10 A.M. on January 23, 2006 until February 6, 2006 at 5:00 P.M. To access the replay, call [phone] (toll free) or [phone], and enter passcode 5500.

Founded in 1996, PetMed Express is America`s largest pet pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

[Koopie242]

einfach nur hammer. Nasdaq: +18%, Frankfurt +17%.
Hoffentlich gehts weiter so.Will ende des jahres die 20€ sehen

[MrMoose]

Gibt es noch Meinungen zu diesem Wert? Möchte eigentlich gerne einsteigen. Ist ja ein super Chart mit Zahlen die überzeugen.

[kars10]

Bist Du dabei Mr Moose? Chart ist wirklich fast wie aus dem Bilderbuch.

Quelle: Der Aktionär

Nach einem guten Start ins Jahr ist dieses Musterportfolio mittlerweile beinahe ganz am Ende der Börsenwelt-Wertung angekommen. Deswegen wird nun das Depot leer gemacht und mit fünf neuen Kandidaten bestückt.

Die Verantwortlichen für das Musterportfolio von Der Darvas Investor haben mit der Aktie von CE Franklin auch den letzten verbliebenen Wert ausgebucht. Es soll aber eine 100-Prozent-Investitionsrate angestrebt werden, weil die Rentenmärkte in den USA stark waren, Finanzwerte deutlich zugelegt haben und damit den US-Markt freundlich tendieren ließen und der Nasdaq sich bei einem erhöhten Handelsvolumen bis auf zwei Prozent an ein Fünf-Jahres-Hoch herangeschoben hat. Zudem ist der für die Darvas-Investitionsstrategie entscheidende Indikator, der NAHL, mit plus 89 Punkten wieder solide im positiven Bereich. Fünf potenzielle Ausbruchskandidaten haben die Depotverantwortlichen ausgesucht, die alle mehr als 180 Prozent seit den Jahrstiefs zugelegt haben, eine so genannte Darvas-Box abgeschlossen haben und in der Nähe zu den Fünf-Jahres-Hochs liegen:

(...)

Auch 350 Aktien von Petmed Express (WKN 121843) sollen ins Musterportfolio. Hier beträgt der Stop-buy_Wert 19,61 Dollar und der Stop-Loss 18,16 Dollar. Die bisherigen Ausbrüche seien immer sehr dynamisch verlaufen. Derzeit konsolidiere die Aktie nach hervorragenden Quartalszahlen.

[MrMoose]

Hallo...mal eine Antwort....ist ja nicht soviel los hier. Bin aber eingestiegen. Mit einer kleinen Position. Könnte ein bisschen mehr gehandelt werden in D. In US ist es ja nicht schlecht. Aber gut Ding will Weile haben.

[MrMoose]

www.finanznachrichten.de

23.03.2006 17:55
Update PetMed Express Inc.: Buy (Wedbush Morgan)
Die Analysten von Wedbush Morgan bewerten in ihrer Analyse vom Donnerstag, 23. März 2006 die Aktie von PetMed Express Inc. (Nachrichten) neu mit dem Rating "Buy". Das Kursziel für die Aktie liegt momentan bei 25 $.

Das sollte doch ein bisschen Bewegung in die ganze Sache bringen.
Gucken wir mal.
Mr.Moose

[kars10]

Hier mal der Jahreschart.



Denke auch, dass es mit Knacken der Marke von 20 Dollar nochmal einen Schub geben könnte.

[Koopie242]

Antwort auf Beitrag Nr.: 20.937.259 von kars10 am 24.03.06 14:10:49

ach du scheiße.schon -14 prozent in usa,wegen einer herabstufung

[MrMoose]

Völlig unbegründet.

Wichtig ist der letzte Satz: "Gristina also believes Petmed will be able to adapt to changes in the industry."

Sogar der Analyst glaubt das es für PetMed kein Problem ist.

Hier die ganze Meldung zur Abstufung:

NEW YORK (AP) -- Shares of Petmed Express Inc. fell sharply Wednesday, after investment firm Avondale Partners said competition from veterinarians during flea and tick season could threaten the pet pharmacy's business.

Shares of Petmed fell $2.71, or 14 percent, to $17.28 in afternoon trading on the Nasdaq Stock Market.

Avondale analyst Frank Gristina lowered Petmed's investment ratings to "market perform" from "market outperform," saying that vet prices, on average, are now in line with the Pompano Beach, Fla., company's. Two years ago, vets were charging about 10 percent more for services.

Gristina said vets appear to be playing to their strengths by charging more for visits, lab work and procedures to bring prices down on "highly contested products."

However, Petmed Chief Financial Officer Bruce Rosenbloom said competition is nothing new to the company.

"Vets have always offered competitive rates. There's more competition in the marketplace, that's something that we've talked about over the past year to two years," he said. "Prices may be similar, but one thing they're missing is the comparison of free shipping and the value that gives to the customer."

He cited rapid home delivery as one way Petmed differentiates itself from traditional vets. He also said the company examines its pricing structure annually.

Gristina also believes Petmed will be able to adapt to changes in the industry

[Koopie242]

Und es geht weiter abwärts. Schon MINUS 9 % in den USA Hört das den nie auf. Der Chart war so schön

[kars10]

Quelle: http://www.tradingmarkets.com

Here are 7 of the top PowerRatings stocks from PowerRatings.net for the week of April 4.

Stocks are rated 1 through 10, with 10 being the highest. Stocks PowerRated 10 have on average outperformed the S&P 500 by a 16.9-1 margin over a one-week period from 1995-2005. Stocks PowerRated 1 & 2 have on average lost money in simulated trading over the next week.

(...)

PetMed Express' (PETS) PowerRating is 8. PETS is bouncing off a selloff on Monday

[kars10]

Antwort auf Beitrag Nr.: 21.077.653 von kars10 am 04.04.06 22:50:42

Bei Forbes.com gibt es einen Artikel u.a. über Petmed

Don't Bite On Pet Stocks
Geoffrey Seiler, FindProfit 04.04.06, 6:00 AM ET

NEW YORK - While bulls and bears rule the stock market, quite often dogs and cats are the kings and queens of the castle at home. These furry creatures are not only members of our families, but they are also indirectly part of the consumer class. In fact, according to the American Pet Products Manufacturers Association, pet owners spent an estimated $35.9 billion on their pets last year. As such, we wanted to examine if any pet-oriented stocks deserve our attention.

The two largest pet-oriented companies are big-box pet supply retailers PetSmart (nasdaq: PETM - news - people ) and Petco Animal Supplies (nasdaq: PETC - news - people ). In 2005, both companies were in investors' doghouses because of underwhelming results. PetSmart finished the year down almost 28%, while Petco was off a whopping 44%. Rising gasoline prices last year hurt the pet supply purveyors more than other retailers, as shoppers decided to save gas by picking up pet food and other necessities at discount stores and supermarkets instead of making separate trips.

In their most recent quarter, PetSmart put up solid results and guidance, while Petco posted decent results and lukewarm guidance. This seems to indicate that consumers are starting to adjust to the higher gas and utility prices they have been burdened with and that their normal spending patterns are starting to return.

After the carnage of 2005, both stocks appear to be value priced. PetSmart currently trades with a trailing price--to-earnings (PE) multiple of about 22 and a forward PE of 17. Management expects to generate "an average of 20% earnings-per-share growth over the long term," putting the stock's price-to-earnings-growth ratio at about 1.0.

Petco, meanwhile, sports a trailing PE of 18, a forward PE of 15, and a PEG of about 0.95. With superior same-store sales growth (4.4% in the fourth quarter versus 2.7% for PetSmart), operating margins (11.6% in Q4 versus 8.8%), and year-over-year earnings growth in 2005, we believe PetSmart deserves the premium at which it currently trades against rival Petco.

Both stocks offer investors an attractive value proposition. A considerable amount of unfavorable news has been priced into these stocks, especially Petco. We would be leery, however, to jump in at this time. Consumers have held up strong despite difficult conditions, but we remain cautious on how much longer the consumer will be able to thrive. Unfortunately for PetSmart, Petco and our furry friends, discretionary income that goes toward pet supplies is one of the first areas to be cut back when consumers begin to feel pinched.

Bucking the trend in pet-related businesses is PetMed Express (nasdaq: PETS - news - people ). This stock has been a small-cap darling. After moving from the over-the-counter bulletin board to the Nasdaq in January 2004, PetMed's shares quickly headed south from the $10-$11 level. After bottoming out at $4 in early August 2004, the stock started to gain some positive momentum, and has since jumped nearly five-fold in less than two years.
PetMed has strung together some solid results, topped off most recently by an excellent quarter showing earnings of 11 cents per share on $25.9 million in revenue, topping analyst earnings estimates by 2 cents per share and revenue estimates by $1 million. The results were good for year-over-year increases of 37% in sales and 25% in earnings.

Financial publications and small-cap enthusiasts have jumped on the PetMed express, and justifiably so. Besides the strong earnings and revenue growth, the company's balance sheet is solid, with no debt and $26.6 million in cash and equivalents. Additionally, customer acquisition costs, an important measure in small companies as they ramp up business, have dropped from $41 in the quarter ending June 2004 to $31 in its most recent quarter.

One area of both opportunity and risk lies in how PetMed currently obtains its medications for resale. As the company stated in its annual report, "substantially all the major pharmaceutical manufacturers have declined to sell prescription and nonprescription pet medications directly to us." If the company can eventually establish direct relationships with pharmaceutical companies, it should be a nice boost to gross margins. However, PetMed's current dependence on outside distributors could lead to inventory or supply problems.

On a valuation basis, PetMed's metrics look fairly reasonable for a stock expected to grow annual earnings at a 35% clip over the next five years. It has a forward PE under 33, a price-to-sales ratio of 3.5, and a PEG of about 1.1. With the company performing well operationally and the stock seemingly reasonably priced, there doesn't appear much not to like about PetMed. However, we do see a few yellow flags. The most glaring is the amount of insider-selling we see at the company.
According to Insiderscore.com (which is owned by FindProfit’s parent company, Indie Research), since November 2005, the chief executive, chief financial officer, four directors and 10% owner Tricon Holdings have all disposed of stock on the open market. Since before the stock received its Nasdaq listing, insider-selling has been prevalent, without one insider purchase to speak of in the last three years. The lack of conviction by management and insiders in the stock makes us wonder if the risks the company faces are greater than many are assuming.

The greatest risk to us seems to be that a well-funded company or two could easily replicate the company's business model if it continues to prosper, perhaps even PetSmart or Petco. The same, of course, could have been said about the business models of eBay (nasdaq: EBAY - news - people ) and Amazon.com (nasdaq: AMZN - news - people ) in their nascent stages, and those companies have done quite well. Nonetheless, these two companies have to be considered more the exception than the norm.

One also has to question how great of a percentage of the pet medication market PetMed will be able to penetrate, especially if competition picks up. In the prescription segment of this business, which represents about 30% of PetMed's sales, veterinarians have been an obstacle to growth. In general, local veterinarians both prescribe and dispense medication to pets. In the past, they have been reluctant to give up this lucrative part of their business, resorting to tactics such as not supplying copies of prescriptions or authorizing the prescriptions to PetMed's pharmacy staff.

The larger part of PetMed's business, however, is nonprescription medication, such as heartworm and flea and tick medication. The company advertises that it sells these products at a steep discount, but a price check for two of its top-selling products against a local New Jersey veterinarian showed little difference, with six-month supplies for Frontline Plus being more expensive at the online pharmacy and Heartgard Plus being less expensive. The lack of price differentiation as advertised brings into question how much of this business the company will be able to continue to take away from local veterinarians. Checks at PetSmart.com and Petco.com found that neither company offered the same products online, but Petco did offer a three-month supply of Frontline that was cheaper than PetMed's three-month supply price.

Ratcheting up its supply business to challenge Petco and PetSmart could also be a difficult task. Consumers haven't previously shown an eagerness to buy pet supplies online and selling dog food is near impossible, lest we not forget the fate of Pets.com and its sock puppet mascot. Thus, while PetMed looks like it could be an investor's best friend, we wouldn't be buying into the hype, at least not until insiders show some conviction. At this point, if the company is able to continue to win business away from local vets, the big fear is that its own near-term success will breed an even bigger risk in the form of greater competition.

While we're not inclined to jump into any of these stocks at the moment, we will continue to keep them on our radar. If the economy shows no signs of slowing and the consumer remains strong, these stocks will likely do well. We’re just not ready to make that bet at this time. If you think consumers will prosper in 2006, though, Petco and PetSmart might not be bad ways to play the retail sector.

[kars10]

Und noch was:

Quelle: chron.com

April 4, 2006, 2:58PM
PetMed Up on 'Buy' Reiteration


© 2006 The Associated Press

NEW YORK — Shares in PetMed Express Inc., an operator of a pharmacy service for animals, rebounded as much as 8 percent Tuesday after Oppenheimer reiterated its bullish rating of the stock, saying the company is well-positioned in a growing market despite concerns of price competition.

In the past week, the stock shed more than 25 percent from an all-time high of $20.20 after investment firm Avondale Partners cut its rating last Tuesday. The firm said veterinarians had lowered prices to compete with PetMed during the upcoming flea and tick season, threatening the company's business.

But on Tuesday, Oppenheimer analyst Amy E. Ryan reiterated her "Buy" rating, saying PetMed differentiates itself by offering "convenience factors" such as automatic refills, free shipping and time savings.

Ryan expects the pet medication sector, estimated at $3 billion, to continue to grow as pets live longer because of improved medication. PetMed holds 4 percent market share, with some 78 percent controlled by a fragmented group of independent veterinarians, Ryan said.

Ryan's reiteration comes a day after Sidoti & Co. analyst Anthony C. Lebiedzinski boosted his rating to "Buy," saying PetMed's services give it an advantage over veterinarians.

The analyst said the recent sell-off, some of which he attributed to profit-taking, was "overdone," and set a target price for the stock of $21.

PetMed shares recently listed up 87 cents, or 5.5 percent, to $16.77 heavy trading on the Nasdaq. The share rose as high as $17.19 earlier Tuesday.

[Koopie242]

Kann mir jemand sagen was das soll, gibt es irgendwelche NEWS???

[MrMoose]

Keine News gefunden. Habe den Eindruck das viele Basher unterwegs sind. Habe im Yahoo Forum das gefunden.

"Called the Company 5/15/06 is earning announcement....."

Auf der Webseite habe ich aber nichts gefunden.

[Koopie242]

weiss einer von euch, wann die nächsten Zahlen kommen.


außerdem sieht es in usa wieder düster aus

[Koopie242]

Ich werde aus dem ganzen nicht schlau, warum die Aktie auf einmal so absackt

[Koopie242]

HALLO WANN KOMMEN DIE QUARTALSZAHLEN; DIE MÜSSTEN DOCH EIGENTLICH POSITIV SEIN; DAMIT DIE AKTIE WIEDR AUFTRIEB BEKOMMT

[Koopie242]

gehts jetzts ganz abwärts, aber wenn warum. In USA wieder 3,5% im MINUS

[Koopie242]

schon wieder fast 6% im MINUS in den USA. WAs ist den hier los.Und News bekommt man auch keine.

weiss den keiner von euch ,wann Quartalszahlen sind

[kars10]

hab auch was vom 15.5. gehört.

für einen solchen kursverlust wie aktuell kann ich keine gerechtfertigten gründe finden.

wollen wir mal hoffen, dass es dann bald wieder nach oben geht.


hier noch ein artikel von miamiherald.com

PetMeds cash in on growing industry
As the $36 billion pet care industry continues to grow, so does the outlook for 1-800-PetMeds, the Pompano Beach-based pet pharmacy.
[e-mail]
BY MONICA HATCHER




As the American family pet continues digging deeper into consumer pocketbooks, a South Florida company that sunk its teeth into the pet product market a decade ago refuses to let go.

Pompano Beach-based PetMed Express, also known as 1-800-PetMeds, began as a small mail-order operation in 1996 with three employees, including founder Marc Puleo.

Their target market then: Broward County dog owners.

Today, with a staff of about 180, the company ships supplies to approximately 1.4 million dog, cat and horse lovers across the 50 states and has ballooned into what analysts say is the largest online pet pharmacy in the country.

During the nine-month period ending Dec. 31, 1-800-PetMeds rang up $108.2 million in sales and $8.9 million in net income -- almost more than its totals for the entire previous year.

But that's still a tiny piece of the $3 billion pet owners spend annually on their animals' medications. Veterinarians continue to dominate the business, and remain fierce competition. Ongoing price wars with vets are followed closely by investors -- an analyst report last March commenting that vets' medicine prices, on average, are no higher than PetMeds' sent the stock tumbling 14 percent. A competing analyst report the following month touting PetMeds' ''convenience factors'' such as automatic refills, free shipping and time savings sent the stock back up again.

The concept behind 1-800-PetMeds began simply, its founder said: offer pet owners the products they already regularly use, but at cheaper prices and more conveniently.

The company's initial inventory included both over-the-counter and prescription pet medications, such as vaccines and heart worm prevention and flea and tick medications, which at that time could only be purchased from veterinarians. It also stocked accessories and grooming supplies.

The company confirms prescriptions with vets before mailing to customers.

RAPID SUCCESS

The idea took off immediately, said Puleo, who was working as an anesthesiologist at North Ridge Medical Center when he founded the company.

''We put together a little brochure, mailed it out, and just kind of waited for the phones to ring, and they started to ring off the hook,'' Puleo said.

Growth came in fits and starts the next few years, as the company sailed into the maelstrom of the dot-com era.

In 1998, 1-800-PetMeds jumped on the e-business bandwagon and began offering its products from a website. Last year, 57 percent of the company's sales came from its website, 1800PetMeds.com.

But in 1998, finding investors to expand the business and stay competitive was difficult, even though the company was profitable. ''Back then, the company had a great idea,'' said Bruce Rosenbloom, who has been chief financial officer for 1-800 PetMeds since 2001.

For one, he said, it broke the monopoly held by veterinarians on the sale of pet medications, most of which still are not available at retail pet store chains. ''Unfortunately, it got lost among many other ideas,'' he said.

Investors also snubbed the idea of a hybrid model of a mail order and Web-based business, Rosenbloom said. Soon after, the tech bubble blowout brought even more hard times.

''When Pets.com went belly-up, no one would touch us with a 10-foot pole,'' Puleo said. ``We were going paycheck to paycheck.''

TURNAROUND IN 2000

The turnaround came in late 2000, when, after seemingly exhausting its resources, the company found an investor in Miami-based Tricon Holdings, which was willing to inject the cash the company needed to launch an aggressive, nationwide advertising campaign.

Puleo also hired a fresh crew to steer the company into the new millennium with Menderes Akdag, previously of Lens Express, and Rosenbloom signing on as chief executive and CFO, respectively. Puleo is chairman of the board and president of the company.

``In 2001, when I joined the company, they had $10 million in sales, but they were losing $2.8 million.''

The company stock had hit an all-time low of 20 cents a share.

Company officers set to work paring down their product line from 2,000 items to the 750 that represented the majority of their sales. They pumped millions into advertising, which remains one of their biggest expenses. People started buying and the stock rose to a high of $20.20 in March. That's when shares took a hit after analysts said vets were lowering their prices on medications during the spring and summer flea and tick season, potentially taking business away. The stock now trades around $16.

Although PetMeds still has a 4 percent piece of the medicinal pie, the booming demand for pet care products means the pie itself is growing.

''People are looking more and more at pets as being parts of the family, rather than just dogs and cats,'' Puleo said. ``And people are spending more money on them and want to keep them healthy.''

[MrMoose]

Empfehlung und heute immerhin in den US mal +2,62 in den USA. Hoffen wir mal auf einen weiteren Anstieg.

Money & Investing
Avondale Partners' Frank Gristina
Jody Yen, 05.02.06, 12:00 PM ET

Avondale Partners' Frank Gristina only covers companies where at least 50% of revenue comes from direct-to-consumer segments. This coverage has been richly rewarded; last year Gristina beat his benchmark by 38%, making him the top U.S. stock picker in 2005. He hit a grand slam with his "buy" recommendation on NutriSystem (nasdaq: NTRI - news - people ), which rose 432%. With sales of $213 million last year, NutriSystem provides online weight-loss programs and prepackaged meals. The company is still Gristina's top pick.

Also boosting Gristina's rating in the StarMine system was his "market underperform" call last year on online retailer Overstock.com (nasdaq: OSTK - news - people ), which went down 20% last year. He says the company was only competitive on price, but it fell short on convenience and customer services.

Gristina sees a promising future for online retailing: "When companies provide clear value propositions in terms of price, convenience and quality, consumers are more willing to shop online for both hard goods and perishables." He looks for companies that offer proprietary products and services, such as online video rental service NetFlix (nasdaq: NFLX - news - people ) and online pet pharmacy PetMed Express (nasdaq: PETS - news - people ), stocks that Gristina had as buys last year. They rose 129% and 86%, respectively.

Though NetFlix and PetMed are still on Gristina's "buy" list, he notes that they are not cheap. NetFlix trades for 47 times Gristina's 2006 earnings estimate of 66 cents per share ,and PetMed trades hands at 26 times his forecast of 63 cents per share.

Gristina has been with Avondale Partners, based in Nashville, Tenn., since February 2003. Avondale is an employee-owned investment bank that was founded in 2001.

Current Picks
NutriSystem (nasdaq: NTRI)
NetFlix (nasdaq: NFLX)
PetMed Express (nasdaq: PETS)

[MrMoose]

Der Termin ist bestätigt...Zahlen am 15. Mai



Press Release Source: PetMed Express, Inc.


PetMed Express D/B/A 1-800-PETMEDS To Announce Its Fiscal Year End Financial Results on May 15, 2006
Monday May 8, 8:00 am ET


POMPANO BEACH, Fla.--(BUSINESS WIRE)--May 8, 2006--PetMed Express, Inc. (NASDAQ:PETS - News) will announce its financial results for the year ended March 31, 2006 on Monday, May 15, 2006 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Company's Chief Executive Officer and President, will host a conference call to review the financial results.
ADVERTISEMENT


To access the call, which is open to the public, dial 888-455-1758 (toll free) or 312-470-7365, ten minutes prior to the scheduled start time. Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins.

For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on May 15, 2006 until May 29, 2006 at 11:59 P.M. To access the replay, call 866-365-4158 (toll free) or 203-369-0225, and enter passcode 5500.

Founded in 1996, PetMed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at http://www.1800petmeds.com.

This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company's ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such "forward-looking" statements are set forth in Management's Discussion and Analysis of Financial Condition and Results of Operation in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2005. The Company's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.



Contact:
PetMed Express, Inc., Pompano Beach
Bruce S. Rosenbloom, 954-979-5995
Fax [phone]

--------------------------------------------------------------------------------
Source: PetMed Express, Inc.

[kars10]

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES RECORD FINANCIAL RESULTS FOR FISCAL 2006 - SALES INCREASE 27%, NET INCOME INCREASES 51%


Pompano Beach, Florida, May 15, 2006 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the fiscal year ended March 31, 2006. Net sales for the year ended March 31, 2006 were $137.6 million, compared to $108.4 million for the year ended March 31, 2005, an increase of 27%. Net income was $12.1 million, or $0.50 diluted per share, for the year ended March 31, 2006, compared to net income of $8.0 million, or $0.34 diluted per share, for the year ended March 31, 2005, an increase to net income of 51%. The Company acquired approximately 624,000 new customers during the fiscal year compared to 510,000 during the prior year. Approximately 57% of all orders were placed on our website during the fiscal year.

For the quarter ended March 31, 2006, net sales were $29.4 million, compared to $23.5 million for the quarter ended March 31, 2005, an increase of 25%. Net income for the quarter ended March 31, 2006 was $3.1 million, or $0.13 diluted per share, compared to net income of $2.4 million, or $0.10 diluted per share, for the same quarter the prior year, an increase to net income of 30%. The Company acquired approximately 94,000 new customers during the fourth fiscal quarter compared to 80,000 new customers for the same quarter in the prior year.

Mendo Akdag, CEO and President, commented: "We are pleased to report that our retail reorder sales increased 29%, from $68.7 million to $88.4 million, for the years ended March 31, 2005 and 2006, respectively. We will continue to focus on reorder sales in fiscal 2007 by initiating more relevant personalized communication and health education content to build value for our customers and assist them in choosing the right products for their pets. We invite everyone to visit the newly launched health and education website, Pet Health 101 (www.pethealth101.com)."

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the year end financial results. To access the call which is open to the public, dial [phone] (toll free) or [phone]. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10 A.M. on May 15, 2006 until May 29, 2006 at 11:59 P.M. To access the replay, call [phone] (toll free) or [phone], and enter passcode 5500.

Founded in 1996, PetMed Express is America's largest pet pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company's ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such "forward-looking" statements are set forth in Management's Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2005. The Company's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

[MrMoose]

Hier noch mal kurz und knapp...

PetMed Quarterly Profit Rises 29 Percent
Monday May 15, 9:43 am ET
PetMed Express Posts Higher Fiscal 4th-Quarter Profit Due to Increased Sales

POMPANO BEACH, Fla. (AP) -- Pet pharmaceutical delivery service PetMed Express Inc. on Monday posted higher fiscal fourth-quarter profit as sales jumped 25 percent.
Net income increased to $3.1 million, or 13 cents per share, in the quarter ended March 31, from $2.4 million, or 10 cents per share, in the prior-year quarter.

Earnings were in line analysts' expectations, according to a Thomson Financial survey.

Sales grew to $29.4 million from $23.5 million a year ago. Analysts expected sales of $28.6 million.

For the full year, earnings were $12.1 million, or 50 cents per share, compared with $8 million, or 34 cents per share, in fiscal 2005. Sales rose to $137.6 million from $108.4 million a year ago.



Alles gut, Analysten Erwartungen erfüllt und trotzdem -3.5% in den USA heute...hm...

[Koopie242]

sieht echt übel aus

[kars10]

Quelle: JSOnline
Spending on pets expected to soar
Revenue is mostly recession-proof since they are considered 'family'

By KATHLEEN GALLAGHER
[e-mail]
Posted: May 21, 2006

Fluffy, Fido and Spot tug at their owners' hearts - and in many cases, their wallets.

Petsmart, Inc.

(...)

"Because people are spending more and more on their pets, there will be a push in services like styling salons and doggie day camps, and in pet health care," said Adam Sweet, who is seeking an MBA in finance and is a participant in the school's Applied Security Analysis Program.

About 63% of all U.S. households, or 69.1 million homes, have at least one pet, according to the American Pet Products Manufacturers Association. Sweet says he expects the growth of two demographic groups - children younger than 18 years of age and empty nesters - to drive that number higher over the next few years.

The pet products manufacturers' association points to research showing that having a pet can provide benefits ranging from helping to lower blood pressure to assisting in fighting depression. That, or just the fact that many pet owners view their pets as members of the family, helps drive them to providing the animals with the best of everything.

From monogrammed sweaters to grooming sessions followed by massages and self-cleaning litter boxes, pet owners are anteing up. Pet industry expenditures were $36.3 billion in 2005 and are projected to grow by 5.8% to $38.4 billion in 2006, according to the association.

Ten years ago, such expenditures were $21 billion, according to the association's data.

Even Sweet, a busy graduate student, was out doing his part recently by purchasing a gift to celebrate the birthday of his dog Tanner.

"We bought him a big toy and a bone," Sweet said.

Healthy pets, healthy profits
Pet owners also are spending more on their animals' health care, particularly for preventive care and services that were previously available only to humans, Sweet said. He predicts services and vet care, now a little more than 30% of all pet industry expenditures, will have close to double-digit growth this year and for several years after that.

There are many companies taking advantage of the pet pampering trend. The biggest risk associated with these stocks is that the companies are dependent on consumers' ability to keep spending. But because many pet owners view their pets as members of the family, Sweet says spending in this area is less likely to fall in the event of an overall consumer spending decline.

"One of the things with pet owners is they're very loyal - once they become a customer, they'll continue to buy things," Sweet said.

PetMed Express Inc. (PETS, $13.48), Pompano Beach, Fla., is a pet pharmacy that sells prescription and over-the-counter pet medications and health and nutritional supplements by phone, fax, mail and the Internet.

Investors who think increased prices at the gas pump and rising interest rates may hinder the amount consumers spend on their pets could find a different dynamic at work with this consumer play.

"If gas is up to $4 or $5 a gallon, I'll drive less - but I'm still going to spend the same amount on my pet," Sweet said.

PetMed's stock price has declined recently because the prices veterinary practices charge for medications have come down to the levels PetMed charges after being at a 10% premium, Sweet said. Despite the price wars, he says PetMed looks attractive under $14 a share because more people are turning to the Internet to make their purchases.
Petsmart Inc. (PETM, $27.20), Phoenix, Ariz., operates 826 stores in the U.S. and Canada. The retailer is focusing on being the all-in-one provider, offering not just pet food and supplies, but grooming and day care services and dog training.

"In the last year they've started adding vet clinics and now close to 75% of their stores have vets on site," Sweet said.

Petsmart also has about 30 in-store "PetsHotels," where animals can stay for the day or overnight, and is planning to expand that offering into another 270 stores, he said.

The retailer plans to add 90 stores this year. It has $206 of sales per square foot, almost $20 more than Petco, one of Petsmart's biggest competitors.

"This top-line revenue growth, coupled with the higher operating margins associated with the growing services portion of their business, will drive increased future cash flows and fuel future expansion," Sweet said.

He would buy Petsmart up to $27 and says these shares could go as high as $35 in the next 12 to 18 months.

[Koopie242]

Strong Buy^^

[kars10]

wollen wir mal hoffen, dass es jetzt wieder nach oben geht

PetMed Express initiated with "strong buy"
Friday, June 02, 2006 4:03:22 AM ET
JMP Securities
NEW YORK, June 2 (newratings.com) - Analysts at JMP Securities initiate coverage of PetMed Express Inc (PETS.NAS) with a "strong buy" rating. The target price is set to $17.

In a research note published yesterday, the analysts mention that the current valuation of PetMed Express' stock is attractive, following the significant decline in the company's share price. PetMed Express has a profitable operating model and its healthy balance sheet offers flexibility, offering a competitive advantage, the analysts say. The company is expected to generate 20%-25% earnings growth in the forthcoming two years, according to JMP Securities.

[kars10]

Quelle: Cincinnati Business Courier
Kendle to join SmallCap 600
Cincinnati Business Courier - 10:56 AM EDT Tuesday
Standard & Poor's announced Monday that Kendle International Inc. will join its stable of companies in the SmallCap 600 index.
The index invests in and tracks 600 companies with a market capitalization of $300 million to $2 billion. Kendle will be added at an undetermined date, and will replace SBS Technology (NASDAQ: SBSE), which is being acquired by a unit of General Electric Co. (NYSE: GE). Florida-based PetMed Express Inc. (NASDAQ: PETS) will also join the index, replacing Thomas Nelson (NYSE: TNM), which is also being acquired.
------------------------------

StreetInsider.com Pre-Open Movers 06/06
PetMed Express Inc. (NASDAQ: PETS) 5% HIGHER; will replace Thomas Nelson (NYSE: TNM) in the SmallCap 600 after the close of trading on Monday, June 12, 2006.

------------------------------

Quelle: BusinessWeek
PetMed shares rise on addition to index
UN. 6 12:59 P.M. ET Shares of veterinary medication delivery company PetMed Express jumped Tuesday, after Standard & Poor's said it will add the Pompano Beach, Fla., company to its SmallCap 600 index.
PetMed shares added 81cents, or 6.3 percent, to $13.75 in midday trading on the Nasdaq on heavy volume. The shares have traded in a 52-week range of $7.20 to $20.20.
After the close Monday, Standard & Poor's said it will add the company, which it referred to as "the largest pet pharmacy in the U.S." to the index after the end of regular trading on June 12. It will replace Thomas Nelson, which is being acquired by InterMedia Partners LP, a private equity group

[kars10]

Quelle: newratings.com

PetMed Express "buy"
Thursday, July 13, 2006 2:49:56 AM ET
Wedbush Morgan Securities
NEW YORK, July 13 (newratings.com) - In a research note published yesterday, analyst William J Lennan Jr of Wedbush Morgan maintains his "buy" rating on PetMed Express Inc (PETS.NAS). The target price is set to $19

[kars10]

PetMed Express D/B/A 1-800-PetMeds to Announce Its First Quarter Financial Results on July 24, 2006
POMPANO BEACH, Fla.--(BUSINESS WIRE)--July 17, 2006--

PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2006 on Monday, July 24, 2006 at 8:00 a.m. Eastern time, then at 8:30 a.m. Eastern time, Menderes Akdag, the Company's Chief Executive Officer and President, will host a conference call to review the financial results.

[kars10]

Antwort auf Beitrag Nr.: 22.645.541 von kars10 am 17.07.06 16:05:43

Falls es überhaupt noch jemand gibt den es interessiert:
Quelle: 1800petmeds.com
PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS - NET INCOME INCREASES 34% TO RECORD $0.20 EPS

Pompano Beach, Florida, July 24, 2006 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2006. Net income was $4.8 million, or $0.20 diluted per share, for the quarter ended June 30, 2006, compared to net income of $3.5 million, or $0.15 diluted per share, for the quarter ended June 30, 2005, an increase to net income of 34%. Net sales for the quarter ended June 30, 2006 were $50.7 million, compared to $43.6 million for the quarter ended June 30, 2005, an increase of 16%. Approximately 59% of all sales were placed on the Company's website for the first fiscal quarter, compared to 54% for the same quarter in the prior year.

Menderes Akdag, CEO and President, commented: "We are pleased to report that our retail reorder sales increased by 32%, from $25.8 million to $33.9 million for the quarters ended June 30, 2005 and 2006, respectively. We will continue to focus on reorder sales in fiscal 2007 by initiating more relevant personalized communication and health education content to build value for our customers and assist them in choosing the right products for their pets. Earlier in the year we made a strategic business decision to focus more on retail customers, and to limit wholesale sales. Our retail sales, excluding wholesale sales, increased by 19%, compared to an increase of 21% for the same quarter in the prior year. We are also pleased to report that net cash provided by operating activities increased by $1.8 million, from $8.0 million for the quarter ended June 30, 2005 to $9.8 million for the quarter ended June 30, 2006."

[Koopie242]

müsste langsam wieder aufwärts gehen.indikatoren stehen dafür auch net schlecht.

Auf zu alten Höhen

[kars10]

Quelle: http://money.cnn.com

PetMed Express: Catnip for your portfolio
The retailer behind the 1-800-PetMeds ads is growing fast and its stock is a bargain.
By Katie Benner
October 19 2006: 12:54 PM EDT


(Fortune) -- In a world where pets are treated to designer duds, gourmet meals, luxury hotel rooms, and high-end cab services, people's devotion to animals has unleashed a giant opportunity for PetMed Express (Charts).

The Pompano Beach, Fla.-based retailer - which sells pet medications, gifts and other products by phone, online and snail mail - has gone from being a penny stock in 2000 to a fast-growth company whose shares trade in the double digits. And we think this puppy has more room to grow.

Americans are expected to spend about $38.4 billion this year on their pets, up 35 percent from 2001, according to the American Pet Products Manufacturers Association. PetMed dominates a lucrative specialty - prescription animal drugs sold outside the traditional veterinarian's office channel. Because these medications are tightly controlled, they're not available in brick-and-mortar stores. And buyers increasingly are taking the mail-order approach: Five years ago, less than 1 percent of owners whose pets take medication bought it outside a vet's office, according to the company. Now up to 9 percent do, and even better, PetMed says it has more than half of that market.

PetMed has used prescription medication as a way to break into the competitive, fragmented pet-supply market - creating a convenient, aggressively priced, one-stop shop for pet owners. Owners who want, say, a doggy bed no longer have to trek to big retailers like Wal-Mart (Charts), Costco (Charts) or Target (Charts), and then to a small local pet shop to buy Kitty's vitamins.

Customers seem to like the convenience. The company posted annual sales of $137.6 million for the fiscal year ending March 2006, up 27% from the previous year. And quarterly sales continue to show double-digit growth. No wonder, then, that many high-growth, small-cap and emerging companies mutual funds, including those offered by Vanguard, Allianz CCM and American Century, have PetMed in their portfolios.

But shares now are trading at around $11, close to their 52-week low, and almost half their 52-week high of $20.20. Why? Wall Street is worried mostly about rising advertising costs and disappointing new-customer numbers. With PetMed set to report quarterly earnings Monday, will its stock find a way out of the doghouse?

Pet peeves
PetMed began its retreat from $20 this April, and analysts say the sag was due in large part to concerns that election-year TV spots are making their signature 1-800-PetMeds ads very expensive. Avondale Partners lowered its rating on the stock to "market perform" from "market outperform" at the end of March and JMP Securities downgraded the company to "market outperform" from "strong buy" early this September. Both companies cited advertising costs.

While the company understands investors' worries about ad costs, TV spots are the company's "bread and butter" when it comes to attracting new customers, said PetMed CFO Bruce S. Rosenbloom. Meanwhile, existing customers are proving as loyal as man's best friend, with return business soaring 30 percent in the last quarter, beating expectations.

"More of our marketing activities are being directed at our existing base through e-mails and mailings," said Rosenbloom, which could help keep costs down at a time when TV ads are expensive.

And if need be, the company would consider raising prices, company executives told investors at a conference hosted by Wedbush Morgan Securities in September.

Meanwhile, some investors and analysts worry that PetMed could face inventory shortfalls because it cannot source its drugs directly from manufacturers like a veterinarian can. Due to competitive reasons, the company will not disclose who exactly they buy from, but this network includes other wholesalers and distributors and some smaller, secondary manufacturers. However, Rosenbloom says that with 100 to 150 active supply sources the company is unlikely to run out of products.

Some investors may also be nervous about a pending lawsuit. Co-founder Yali Golan is suing former president and chairman and fellow co-founder Marc Puleo in a pay dispute. The original suit, which seeks unspecified damages, included only the two men when it was filed in 2003, but PetMed was added as a defendant in 2006. Neither of the men are still with the company. Michael Friedman, an analyst with Noble Financial Group, says the suit doesn't relate to company performance and Wall Street seems unfazed by the litigation.

Warm and fuzzy outlook
Despite some potential shakiness in the near term, we think PetMed is a smart company and a long-term buy. As more animal lovers discover the company, its market is likely to increase. PetMed stock trades at a reasonable P/E of 15.5 (compared with an average 29 for other drug delivery stocks) and the company has become the biggest name in the pet medication space.

When earnings are released Monday, the stock may sink if the company's ad or sales numbers don't meet analysts' lowered expectations. So we recommend waiting to see how the stock reacts to earnings; it could become an even better bargain buy. Give it some time, and the stock may just become the pet of your portfolio.

[kars10]

Quelle: http://www.1800petmeds.com/pressroom.asp?id=48&adate=10.23.2006

PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS – NET INCOME INCREASES 22%

Pompano Beach, Florida, October 23, 2006 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended September 30, 2006. Net income was $3.3 million, or $0.14 diluted per share, for the quarter ended September 30, 2006, compared to net income of $2.7 million, or $0.11 diluted per share, for the quarter ended September 30, 2005, an increase to net income of 22%. Net sales for the quarter ended September 30, 2006 were $43.8 million, compared to $38.7 million for the quarter ended September 30, 2005, an increase of 13%. Net income was $8.1 million, or $0.33 diluted per share, for the six months ended September 30, 2006, compared to net income of $6.3 million, or $0.26 diluted per share, for the six months ended September 30, 2005, an increase to net income of 29%. Net sales for the six months ended September 30, 2006 were $94.5 million, compared to $82.3 million for the six months ended September 30, 2005, an increase of 15%. Approximately 62% of all sales were placed on the Company’s website for the second quarter, compared to 55% for the same quarter in the prior year.

Menderes Akdag, CEO and President, commented: “We are pleased to report that our retail reorder sales increased by 23%, from $22.9 million to $28.1 million for the quarters ended September 30, 2005 and 2006, respectively. For the six months ended September 30, 2006 our retail reorder sales increased by 28% to $62.0 million from $48.6 million for the six months ended September 30, 2005. We are currently focused on optimizing our advertising campaigns and improving our current service levels to capture additional market share. We are also pleased to report that net cash provided by operating activities increased by $1.5 million, from $12.7 million for the six months ended September 30, 2005 to $14.2 million for the six months ended September 30, 2006.”

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call which is open to the public, dial [phone] (toll free) or [phone]. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10 A.M. on October 23, 2006 until November 6, 2006 at 10:59 P.M. To access the replay, call [phone] (toll free) or [phone], and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2006. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

[Koopie242]

Ist den hier keiner mehr, der in Petmed investiert ist?

[kars10]

ist wirklich ganz schön ruhig hier. aber der kurs scheint sich ja immerhin wieder gefangen zu haben.

an news gab es aber zuletzt zwar nicht so viel zu vermelden, aber vielleicht gelangt petmed mit der neuen werbekampagne wieder verstärkt ins blickfeld der anleger.

Quelle: http://southflorida.bizjournals.com/southflorida/stories/2007/01/01/daily15.html
White to appear in pet health ads
South Florida Business Journal - January 3, 2007

Beginning this week, PetMed Express said it will feature actress Betty White in its 2007 advertising campaign, including new national commercials.

The animal rights advocate and author of "Betty White's Pet Love" is to speak about the value of using flea, tick and heartworm medications year-round.

White serves on the Morris Animal Foundation, a national group dedicated to improving the health of companion animals.

The Emmy Award-winning actress is also known for her roles on "The Mary Tyler Moore Show" and "The Golden Girls." Recently, she has made guest appearances on "The Bold and The Beautiful" and "Boston Legal."

[Koopie242]

oooooooohhhhhh ooooooh, sieht nicht gut heute aus, jetzt schon fast 8% minus in USA. Anscheinend nicht zufriedenstellende Zahlen, oje oje^^

[kars10]

Quelle: http://www.bradenton.com/mld/bradenton/news/nation/16518232.htm

PetMed Express third-quarter earnings flat
Earnings for Pompano Beach's PetMed Express, which sells pet medications and products online, were flat in the fiscal third quarter, at 11 cents per share. Sales rose 21 percent to $31.4 million over the same quarter last year.

For the nine months ended Dec. 31, sales rose 16 percent to $125.8 million. The company earned 44 cents per share, up from 37 cents.

PetMed Express said the company gained 130,000 new customers in the third quarter. Its focus in 2007 will be on expanding market share and improving customer service.

[Koopie242]

eigentlich ja keine schlechten Zahlen, aber heutzutage ist gut nicht gut genug

[kars10]

es gab wohl von analystenseite höhere erwartungen:

http://www.marketwatch.com/news/story/petmed-express-third-quarter-net-up/story.aspx?guid=%7B834F9E09-08D4-42DE-8350-4AF5BF9A9934%7D:
"Analysts surveyed by Thomson Financial expected, on average, earnings of 15 cents a share on revenue of $34 million."

aktuel 10% im minus - das sieht wirklich übel aus.

andererseits sind 130,000 neue kunden im letzten quartal doch ein ungebrochen guter wert, der auf eine positive entwicklung hoffen lässt.

mal sehen, was die nächsten tage/wochen bringen...

[Koopie242]

-15%

[MODzart]

Viel Spaß beim weiteren Schreiben.

Habe die Ehre,
MODzart

[kars10]

Mal wieder sehr erfreuliche News von Petmed mit besseren Zahlen als erwartet:

Quelle: 1800petmeds.com
PETMED EXPRESS D/B/A 1-800-PETMEDS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS – NET INCOME INCREASES 30% TO RECORD $0.25 EPS

Pompano Beach, Florida, July 23, 2007 - PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended June 30, 2007. Net income was $6.2 million, or $0.25 diluted per share, for the quarter ended June 30, 2007, compared to net income of $4.8 million, or $0.20 diluted per share, for the quarter ended June 30, 2006, an increase to net income of 30.2%. A one-time income tax-related net benefit was recognized in the quarter ended June 30, 2007, resulting in an increase to diluted earnings of one-half of a penny ($0.005) per share. Net sales for the quarter ended June 30, 2007 were $59.0 million, compared to $50.7 million for the quarter ended June 30, 2006, an increase of 16.5%. Reorder sales increased by 18%, from $33.9 million to $40.0 million for the quarters ended June 30, 2006 and 2007, respectively.

Menderes Akdag, CEO and President, commented: “We are pleased to report that our new order sales increased by 15%, from $16.5 million to $19.0 million for the quarters ended June 30, 2006 and 2007, respectively. We were also more efficient with our advertising spending this quarter, with a new customer acquisition cost of $36 for the quarter, compared to $40 for the same quarter in the prior year. We acquired approximately, 236,000 new customers for our first fiscal quarter compared to 207,000 for the same quarter in the prior year. We are also pleased to report that our Internet sales increased by 26%, to $37.9 million for the quarter ended June 30, 2007, compared to $30.1 million for the same quarter in the prior year. Approximately 64% of all sales were placed on the Company’s website for the first fiscal quarter, compared to 59% for the same quarter in the prior year. We will continue to focus on capturing additional market share, and on improving reorders and our customer service levels in fiscal 2008. Additionally, the Company repurchased 117,300 shares of its outstanding common stock for approximately $1,512,000 during the first quarter of fiscal 2008.”

[kars10]

Antwort auf Beitrag Nr.: 30.830.176 von kars10 am 24.07.07 17:18:45

Quelle: newratings.com
PetMed Express "market outperform," target price raised - update
Monday, July 23, 2007 5:09:35 PM ET
JMP Securities

NEW YORK, July 23 (newratings.com) - Analyst Kristine Koerber of JMP Securities reiterates her "market outperform" rating on PetMed Express Inc (PETS.NAS), while raising her estimates for the company. The target price has been raised from $14 to $17.

In a research note published this morning, the analyst mentions that the company is expected to post robust earnings growth in F1Q08, with EPS ahead of the estimates and the consensus. Despite an increased level of spending directed towards television advertising in the quarter, PetMed Express’ management of customer acquisition costs was encouraging, the analyst says. The EPS estimate for FY08 has been raised from $0.71 to $0.73.

-----

Quelle: http://investing.reuters.co.uk
UPDATE 2-PetMed Express Q1 profit up; shares hit year-high
Mon Jul 23, 2007 8:13 PM BST

July 23 (Reuters) - Pet pharmacy PetMed Express Inc. (PETS.O: Quote, Profile , Research) reported quarterly profit that topped analysts' estimate, driven by a big jump in its reorder and Internet sales, and lower advertising expenses.
Shares of the company, which delivers pet medications and other health products for dogs, cats and horses, were trading up nearly 10 percent at $15.15, after hitting a year-high of $15.25 earlier on Monday.

Edward Woo, analyst with Wedbush Morgan, said in a note to clients that investors were pleased with the company for effectively managing advertising costs and spending less on advertising, while growing its customer base.

PetMed's new customer acquisition cost for the quarter was $36, compared with $40 in the prior year.

Woo, who raised his price target by $3 to $12, said the company has benefited from efficient advertising for the last two quarters and he expects it to continue for the next couple of quarters.

He, however, maintained his "hold" rating on the stock.

The company said quarterly earnings rose more than 29 percent to $6.2 million, or 25 cents a share, from $4.8 million, or 20 cents a share, a year ago.

Net sales rose more than 16 percent to $59 million.

The company said it recorded a one-time income tax-related gain that added one-half of a penny per share to its earnings.

Analysts on average were expecting 23 cents a share, before exceptional items, on revenue of $61 million, according to Reuters Estimates.

PetMed Express said total sales were helped by an 18 percent rise in reorder sales during the quarter. New order sales rose 15 percent while Internet sales jumped 26 percent. (Reporting by Aditi Samajpati in Bangalore)

[kars10]

Quelle: http://publications.mediapost.com/index.cfm?fuseaction=Articles.showArticleHomePage&art_aid=69636

PetMed Express' Net Income Increases 37% in Q2
by Tanya Irwin, Tuesday, Oct 23, 2007 5:00 AM ET
WHILE OTHER RETAILERS STRUGGLE, IT'S a dog's life at PetMed Express.

The Pompano Beach, Fla.-based Internet retailer saw a whopping 18% increase for second-quarter sales versus a year ago, and a 17% increase for the first six months of 2007 vs. a year ago. The company's second-quarter net income increased 37%, to $4.5 million, or $0.18 diluted per share, versus net income of $3.3 million, or $0.14 diluted per share, for the same quarter in 2006.

Menderes Akdag, CEO/president of the company, said during a conference call with analysts Monday morning that he was pleased with the results. Asked if he attributed the quarter's success to the national advertising campaign featuring actress Betty White, which started in January he said: "The numbers don't lie, obviously."

Net sales for the quarter ended Sept. 30 were $51.5 million, compared to $43.8 million for the same quarter in 2006. Net sales for the six months ended Sept. 30 were $110.6 million, compared to $94.5 million for the same period in 2006.

Of that total, reorder sales increased by 25%, from $28.1 million to $35.0 million, for the quarters ended Sept. 30, 2007 and 2006, respectively, and for the six months ended Sept. 30, 2007, reorder sales increased by 21%, to $75.0 million, compared to $62.0 million for the six months in the prior year.

"We are doing a better job of communicating with our customer base," Akdag told analysts. "We are communicating more often, staying in front of them, basically."

For the quarter, the company spent $8.1 million on advertising compared to $7.7 million for same quarter a year earlier, for an increase of 5%, Akdag says. For the first six months of the year, the company spent $16.6 million compared to $16 million a year ago, an increase of 4%.

In the national TV spots, White speaks to pet owners from what appears to be her home about the value of using flea, tick and heartworm medications year-round, which is important to protect pets from skin irritations, allergies and diseases.

The company acquired approximately 222,000 new customers in this year's second quarter versus 212,000 for the same quarter in the prior year. Internet sales increased by 23%, to $33.7 million for the quarter, versus $27.4 million for the same quarter in the prior year, and for the six months ended Sept. 30 Internet sales increased by 24%, to $71.6 million, compared to $57.6 million for the same six months in the prior year.

Approximately 65% of all sales were placed on the company's web site for the second fiscal quarter, compared to 62% for the same quarter in the prior year.

The company will focus its upcoming efforts in three areas to capitalize on the pet industry growth trend, says Akdag. They are: 1) capturing additional market share, 2) increasing reorders with personalized communication and health education content and 3) improving current service levels. The company is revamping its web site, which will result in better customer service, he adds, though he gave no date for the site going live.